|
1B2V
HEME-BINDING PROTEIN A
Deposited 1998-12-01
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–188(188 aa)
|
Not recorded
|
CA CALCIUM ION × 1
HEM PROTOPORPHYRIN IX CONTAINING FE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 4.6;0.2M CACL, 0.1M NA ACETATE PH 4.6, 20% ISOPRPANOL
|
Resolution 1.90 Å
R-free 0.218
|
|
1DK0
CRYSTAL STRUCTURE OF THE HEMOPHORE HASA FROM SERRATIA MARCESCENS CRYSTAL FORM P2(1), PH8
Deposited 1999-12-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–188(188 aa)
|
Not recorded
|
HEM PROTOPORPHYRIN IX CONTAINING FE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.1M NaHepes, pH8.0, 1.4M NaKTartrate, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.77 Å
R-free 0.213
|
|
1DK0
CRYSTAL STRUCTURE OF THE HEMOPHORE HASA FROM SERRATIA MARCESCENS CRYSTAL FORM P2(1), PH8
Deposited 1999-12-06
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–188(188 aa)
|
Not recorded
|
HEM PROTOPORPHYRIN IX CONTAINING FE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;293 K;0.1M NaHepes, pH8.0, 1.4M NaKTartrate, VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 1.77 Å
R-free 0.213
|
|
1DKH
CRYSTAL STRUCTURE OF THE HEMOPHORE HASA, PH 6.5
Deposited 1999-12-07
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–188(188 aa)
|
Not recorded
|
ZN ZINC ION × 3
SM SAMARIUM (III) ION × 1
HEM PROTOPORPHYRIN IX CONTAINING FE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;Cacodylate buffer pH6.5,
Zinc Acetate 140mM,
Glycerol 2%,
PEG8000 10%,
Samarium Chloride 10mM., VAPOR DIFFUSION, HANGING DROP, temperature 293K
|
Resolution 3.20 Å
R-free 0.288
|
|
1YBJ
Structural and Dynamics studies of both apo and holo forms of the hemophore HasA
Deposited 2004-12-21
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
2–179(178 aa)
|
Not recorded
|
No recorded non-water small molecule
|
SOLUTION NMR
NMR measurement conditions
pH 5.6;303 K;Ionic strength (raw mmCIF value) 20mM sodium phosphate buffer;Pressure ambient
NMR sample composition
1.8mM HasA 15N | 20mM sodium phosphate buffer, pH5.6; 90% H2O/10% D20
NMR sample composition
1.9mM HasA 15N,13C | 20mM sodium phosphate buffer, pH5.6; 90% H2O/10% D20
|
Resolution not provided
|
|
2CN4
The crystal structure of the secreted dimeric form of the hemophore HasA reveals a domain swapping with an exchanged heme ligand
Deposited 2006-05-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
2–174(173 aa)
Chain B
2–174(173 aa)
|
Not recorded
|
HEM PROTOPORPHYRIN IX CONTAINING FE × 2
PO4 PHOSPHATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8.5;2 MICROLITERS PROTEIN (AT A CONCENTRATION OF ABOUT 4 MG/ML) WERE MIXED WITH 1 MICROLITER RESERVOIR CONSISTING OF 100 MM TRIS BUFFER AT PH 8.5, 2 M K2HPO4 AND 2 M NAH2PO4.
|
Resolution 2.30 Å
R-free 0.224
|
|
2UYD
Crystal structure of the SmHasA mutant H83A
Deposited 2007-04-04
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain X
1–188(188 aa)
|
Mutation:YES
|
HEM PROTOPORPHYRIN IX CONTAINING FE × 1
ZN ZINC ION × 8
ACT ACETATE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 6.5;293 K;DROPS WERE PREPARED BY MIXING 2MICROL OF THE PROTEIN SOLUTION WITH 1 MICROL OF THE RESERVOIR SOLUTION THAT CONTAINED 100 MM SODIUM CACODYLATE AT PH 6.5, 200 MM ZN(OAC)2 AND 10 % (V/V) 2-PROPANOL. THE BROWNISH CRYSTALS GREW OVER A PERIOD OF 2 MONTHS AT 20 DEGREES C.
|
Resolution 2.70 Å
R-free 0.274
|
|
3CSN
Structure of the Serratia marcescens hemophore receptor HasR in complex with its hemophore HasA
Deposited 2008-04-10
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
2–188(187 aa)
|
Not recorded
|
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;291 K;2 M NaCl, 100 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 3.00 Å
R-free 0.244
|
|
3CSN
Structure of the Serratia marcescens hemophore receptor HasR in complex with its hemophore HasA
Deposited 2008-04-10
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
2–188(187 aa)
|
Not recorded
|
GOL GLYCEROL × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;291 K;2 M NaCl, 100 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 3.00 Å
R-free 0.244
|
|
3DDR
Structure of the Serratia marcescens hemophore receptor HasR-Ile671Gly mutant in complex with its hemophore HasA and heme
Deposited 2008-06-06
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
2–188(187 aa)
|
Not recorded
|
NA SODIUM ION × 1
GOL GLYCEROL × 1
HEM PROTOPORPHYRIN IX CONTAINING FE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;291 K;2 M NaCl, 100 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.80 Å
R-free 0.262
|
|
3DDR
Structure of the Serratia marcescens hemophore receptor HasR-Ile671Gly mutant in complex with its hemophore HasA and heme
Deposited 2008-06-06
|
Different ligand/ion
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
2–188(187 aa)
|
Not recorded
|
NA SODIUM ION × 1
GOL GLYCEROL × 5
HEM PROTOPORPHYRIN IX CONTAINING FE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 8;291 K;2 M NaCl, 100 mM Tris, pH 8.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K
|
Resolution 2.80 Å
R-free 0.262
|
|
5C58
A double mutant of serratia marcescens hemophore receptor HasR in complex with its hemophore HasA and heme
Deposited 2015-06-19
|
Different construct
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
2–188(187 aa)
Fragment:UNP residues 2-188
|
Not recorded
|
HEM PROTOPORPHYRIN IX CONTAINING FE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;291 K;100mM Tris pH 7 to 8, 1.8 to 2.2mM NaCl, 100mM K2HPO4
|
Resolution 2.79 Å
R-free 0.296
|
|
9XOH
Crystal Structure of Redesigned HasAsm Variant (14-mutation) with Iron Tetraphenylporphyrin
Deposited 2025-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–176(176 aa)
|
Mutation:A2S, G13A, H17A, G21T, S42T, Q63N, N79S, D102T, V110N, D112E, A125S, V131E, G145S, D156K
|
MQP [5,10,15,20-tetraphenylporphyrinato(2-)-kappa~4~N~21~,N~22~,N~23~,N~24~]iron × 1
GOL GLYCEROL × 3
NA SODIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1M sodium cacodylate-HCl, 1M sodium citrate tribasic
|
Resolution 1.51 Å
R-free 0.234
|
|
9XOH
Crystal Structure of Redesigned HasAsm Variant (14-mutation) with Iron Tetraphenylporphyrin
Deposited 2025-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
1–176(176 aa)
|
Mutation:A2S, G13A, H17A, G21T, S42T, Q63N, N79S, D102T, V110N, D112E, A125S, V131E, G145S, D156K
|
MQP [5,10,15,20-tetraphenylporphyrinato(2-)-kappa~4~N~21~,N~22~,N~23~,N~24~]iron × 1
GOL GLYCEROL × 2
NA SODIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1M sodium cacodylate-HCl, 1M sodium citrate tribasic
|
Resolution 1.51 Å
R-free 0.234
|
|
9XOH
Crystal Structure of Redesigned HasAsm Variant (14-mutation) with Iron Tetraphenylporphyrin
Deposited 2025-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
1–176(176 aa)
|
Mutation:A2S, G13A, H17A, G21T, S42T, Q63N, N79S, D102T, V110N, D112E, A125S, V131E, G145S, D156K
|
MQP [5,10,15,20-tetraphenylporphyrinato(2-)-kappa~4~N~21~,N~22~,N~23~,N~24~]iron × 1
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1M sodium cacodylate-HCl, 1M sodium citrate tribasic
|
Resolution 1.51 Å
R-free 0.234
|
|
9XOH
Crystal Structure of Redesigned HasAsm Variant (14-mutation) with Iron Tetraphenylporphyrin
Deposited 2025-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
1–176(176 aa)
|
Mutation:A2S, G13A, H17A, G21T, S42T, Q63N, N79S, D102T, V110N, D112E, A125S, V131E, G145S, D156K
|
MQP [5,10,15,20-tetraphenylporphyrinato(2-)-kappa~4~N~21~,N~22~,N~23~,N~24~]iron × 1
GOL GLYCEROL × 2
NA SODIUM ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1M sodium cacodylate-HCl, 1M sodium citrate tribasic
|
Resolution 1.51 Å
R-free 0.234
|
|
9XOK
Crystal Structure of Redesigned HasAsm Variant (51-mutation) with Iron Tetraphenylporphyrin
Deposited 2025-11-13
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
3–173(171 aa)
|
Mutation:;F11L, G12D, G13N, Y14L, S15T, I16L, H17Q, D18E, Y19F, L20F, G21N, Q22E, S25A, T26S, S58T, A61K, N62D, Q63G, Q88T, S93A, D96N, D102S, T103S, S104T, Q109T, V110E, D112Q, V113F, S114R, F115L, N119G, L120W, S121T, L123E, Q124I, A125S, Q126E, T144S, G145T, A146P, E148L, T149Q, G153N, I154Q, D156Q, D157Q, V162T, D167M, Q168E, V169I, A170R
;
|
MQP [5,10,15,20-tetraphenylporphyrinato(2-)-kappa~4~N~21~,N~22~,N~23~,N~24~]iron × 1
SO4 SULFATE ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 6.5;293 K;0.1M sodium cacodylate-HCl, 2M ammonium sulfate, 0.2M NaCl
|
Resolution 1.80 Å
R-free 0.330
|
|
9XPD
Crystal Structure of Redesigned HasAsm Variant (51-mutation) with Heme
Deposited 2025-11-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–176(176 aa)
|
Mutation:;F11L, G12D, G13N, Y14L, S15T, I16L, H17Q, D18E, Y19F, L20F, G21N, Q22E, S25A, T26S, S58T, A61K, N62D, Q63G, Q88T, S93A, D96N, D102S, T103S, S104T, Q109T, V110E, D112Q, V113F, S114R, F115L, N119G, L120W, S121T, L123E, Q124I, A125S, Q126E, T144S, G145T, A146P, E148L, T149Q, G153N, I154Q, D156Q, D157Q, V162T, D167M, Q168E, V169I, A170R
;
|
IMD IMIDAZOLE × 1
CIT CITRIC ACID × 1
GOL GLYCEROL × 1
HEM PROTOPORPHYRIN IX CONTAINING FE × 1
NA SODIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;0.1M imidazole-HCl, 1M sodium citrate tribasic
|
Resolution 1.22 Å
R-free 0.177
|
|
9XPI
Crystal Structure of Redesigned HasAsm Variant (48-mutation) with Heme
Deposited 2025-11-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–176(176 aa)
|
Mutation:;F11L, G12A, G13N, Y14L, S15T, I16L, H17A, D18E, Y19F, L20F, G21N, Q22E, T26Y, N41S, S58T, A61K, N62D, Q63G, N79S, E80P, Q88T, S91A, S93T, D96N, T103S, S104T, Q109V, V110N, D112E, S114T, G116S, L120W, S121T, L123E, A125E, Q126E, Q134K, V136I, G145T, E148L, T149Q, G153S, I154L, D156K, D157Q, V162I, Q168E, V169I
;
|
HEM PROTOPORPHYRIN IX CONTAINING FE × 1
ACT ACETATE ION × 3
ZN ZINC ION × 6
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 8;293 K;0.1M imidazole-HCl, 2.5M NaCl, 0.2M Zinc acetate
|
Resolution 2.16 Å
R-free 0.255
|